Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: A4HA29
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 129 | 133 | PF00656 | 0.666 |
CLV_C14_Caspase3-7 | 252 | 256 | PF00656 | 0.563 |
CLV_NRD_NRD_1 | 151 | 153 | PF00675 | 0.526 |
CLV_NRD_NRD_1 | 288 | 290 | PF00675 | 0.575 |
CLV_PCSK_SKI1_1 | 194 | 198 | PF00082 | 0.499 |
CLV_PCSK_SKI1_1 | 244 | 248 | PF00082 | 0.616 |
DEG_APCC_DBOX_1 | 193 | 201 | PF00400 | 0.555 |
DEG_APCC_DBOX_1 | 243 | 251 | PF00400 | 0.538 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.582 |
DEG_SPOP_SBC_1 | 294 | 298 | PF00917 | 0.745 |
DOC_CYCLIN_yCln2_LP_2 | 72 | 78 | PF00134 | 0.439 |
DOC_USP7_MATH_1 | 126 | 130 | PF00917 | 0.674 |
DOC_USP7_MATH_1 | 249 | 253 | PF00917 | 0.575 |
DOC_USP7_UBL2_3 | 153 | 157 | PF12436 | 0.601 |
DOC_WW_Pin1_4 | 290 | 295 | PF00397 | 0.700 |
LIG_14-3-3_CanoR_1 | 125 | 131 | PF00244 | 0.633 |
LIG_14-3-3_CanoR_1 | 242 | 250 | PF00244 | 0.617 |
LIG_FHA_1 | 100 | 106 | PF00498 | 0.609 |
LIG_FHA_2 | 271 | 277 | PF00498 | 0.584 |
LIG_LIR_Gen_1 | 255 | 265 | PF02991 | 0.475 |
LIG_LIR_Gen_1 | 269 | 280 | PF02991 | 0.605 |
LIG_LIR_Nem_3 | 205 | 211 | PF02991 | 0.513 |
LIG_LIR_Nem_3 | 255 | 261 | PF02991 | 0.509 |
LIG_LIR_Nem_3 | 263 | 268 | PF02991 | 0.565 |
LIG_LIR_Nem_3 | 269 | 275 | PF02991 | 0.588 |
LIG_NRP_CendR_1 | 300 | 301 | PF00754 | 0.775 |
LIG_PCNA_yPIPBox_3 | 56 | 69 | PF02747 | 0.624 |
LIG_SH2_CRK | 258 | 262 | PF00017 | 0.421 |
LIG_TRAF2_1 | 210 | 213 | PF00917 | 0.490 |
MOD_CDK_SPK_2 | 290 | 295 | PF00069 | 0.481 |
MOD_CK1_1 | 201 | 207 | PF00069 | 0.566 |
MOD_CK1_1 | 293 | 299 | PF00069 | 0.703 |
MOD_CK2_1 | 185 | 191 | PF00069 | 0.568 |
MOD_CK2_1 | 207 | 213 | PF00069 | 0.495 |
MOD_CK2_1 | 270 | 276 | PF00069 | 0.519 |
MOD_GlcNHglycan | 187 | 190 | PF01048 | 0.607 |
MOD_GlcNHglycan | 212 | 216 | PF01048 | 0.508 |
MOD_GlcNHglycan | 235 | 239 | PF01048 | 0.612 |
MOD_GSK3_1 | 121 | 128 | PF00069 | 0.574 |
MOD_GSK3_1 | 147 | 154 | PF00069 | 0.399 |
MOD_GSK3_1 | 207 | 214 | PF00069 | 0.494 |
MOD_GSK3_1 | 220 | 227 | PF00069 | 0.484 |
MOD_GSK3_1 | 290 | 297 | PF00069 | 0.668 |
MOD_NEK2_1 | 130 | 135 | PF00069 | 0.591 |
MOD_NEK2_1 | 285 | 290 | PF00069 | 0.627 |
MOD_NEK2_1 | 7 | 12 | PF00069 | 0.539 |
MOD_NEK2_2 | 126 | 131 | PF00069 | 0.556 |
MOD_PK_1 | 295 | 301 | PF00069 | 0.668 |
MOD_PKA_2 | 130 | 136 | PF00069 | 0.614 |
MOD_PKA_2 | 151 | 157 | PF00069 | 0.601 |
MOD_PKA_2 | 185 | 191 | PF00069 | 0.665 |
MOD_PKA_2 | 294 | 300 | PF00069 | 0.532 |
MOD_Plk_1 | 234 | 240 | PF00069 | 0.582 |
MOD_Plk_4 | 64 | 70 | PF00069 | 0.585 |
MOD_ProDKin_1 | 290 | 296 | PF00069 | 0.700 |
MOD_SUMO_rev_2 | 98 | 105 | PF00179 | 0.643 |
TRG_DiLeu_BaLyEn_6 | 9 | 14 | PF01217 | 0.654 |
TRG_ENDOCYTIC_2 | 258 | 261 | PF00928 | 0.423 |
TRG_ER_diArg_1 | 299 | 301 | PF00400 | 0.770 |
TRG_ER_diArg_1 | 81 | 84 | PF00400 | 0.622 |
TRG_Pf-PMV_PEXEL_1 | 56 | 60 | PF00026 | 0.655 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IIA8 | Leptomonas seymouri | 75% | 99% |
A0A1X0P7A5 | Trypanosomatidae | 37% | 96% |
A0A3Q8IB89 | Leishmania donovani | 85% | 99% |
A0A422NN36 | Trypanosoma rangeli | 37% | 99% |
A4HY92 | Leishmania infantum | 85% | 99% |
D0A0M5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 100% |
E9AS24 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 84% | 100% |
Q4QDE9 | Leishmania major | 83% | 100% |
V5B7K2 | Trypanosoma cruzi | 37% | 98% |